| pubmed-article:7523609 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7523609 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:7523609 | lifeskim:mentions | umls-concept:C0040732 | lld:lifeskim |
| pubmed-article:7523609 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:7523609 | lifeskim:mentions | umls-concept:C0038250 | lld:lifeskim |
| pubmed-article:7523609 | lifeskim:mentions | umls-concept:C0018183 | lld:lifeskim |
| pubmed-article:7523609 | lifeskim:mentions | umls-concept:C0019829 | lld:lifeskim |
| pubmed-article:7523609 | lifeskim:mentions | umls-concept:C0024305 | lld:lifeskim |
| pubmed-article:7523609 | lifeskim:mentions | umls-concept:C0439859 | lld:lifeskim |
| pubmed-article:7523609 | lifeskim:mentions | umls-concept:C0332283 | lld:lifeskim |
| pubmed-article:7523609 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:7523609 | pubmed:dateCreated | 1994-11-4 | lld:pubmed |
| pubmed-article:7523609 | pubmed:abstractText | To evaluate (1) the effect of granulocyte colony-stimulating factor (G-CSF) on peripheral-blood stem-cell (PBSC) mobilization; (2) the rate of hematopoietic recovery after G-CSF-mobilized PBSC transplantation; and (3) the outcome of high-dose myeloablative therapy and PBSC transplantation in patients with relapsed or refractory lymphoma. | lld:pubmed |
| pubmed-article:7523609 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7523609 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7523609 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7523609 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7523609 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7523609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7523609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7523609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7523609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7523609 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7523609 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:7523609 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:7523609 | pubmed:author | pubmed-author:SnyderD SDS | lld:pubmed |
| pubmed-article:7523609 | pubmed:author | pubmed-author:MolinaAA | lld:pubmed |
| pubmed-article:7523609 | pubmed:author | pubmed-author:ParkerP MPM | lld:pubmed |
| pubmed-article:7523609 | pubmed:author | pubmed-author:SchmidtG MGM | lld:pubmed |
| pubmed-article:7523609 | pubmed:author | pubmed-author:SmithE PEP | lld:pubmed |
| pubmed-article:7523609 | pubmed:author | pubmed-author:SniecinskiII | lld:pubmed |
| pubmed-article:7523609 | pubmed:author | pubmed-author:O'DonnellM... | lld:pubmed |
| pubmed-article:7523609 | pubmed:author | pubmed-author:NademaneeAA | lld:pubmed |
| pubmed-article:7523609 | pubmed:author | pubmed-author:SteinA SAS | lld:pubmed |
| pubmed-article:7523609 | pubmed:author | pubmed-author:DagisA CAC | lld:pubmed |
| pubmed-article:7523609 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7523609 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:7523609 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7523609 | pubmed:authorsComplete | N | lld:pubmed |
| pubmed-article:7523609 | pubmed:pagination | 2176-86 | lld:pubmed |
| pubmed-article:7523609 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:meshHeading | pubmed-meshheading:7523609-... | lld:pubmed |
| pubmed-article:7523609 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7523609 | pubmed:articleTitle | High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells. | lld:pubmed |
| pubmed-article:7523609 | pubmed:affiliation | Department of Hematology/Bone Marrow Transplantation, City of Hope National Medical Center, Duarte, CA 91010. | lld:pubmed |
| pubmed-article:7523609 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7523609 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7523609 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
